AI assistant
Sending…
SUTRO BIOPHARMA, INC. — Director's Dealing 2021
Jan 16, 2021
34319_dirs_2021-01-15_b1e8a74e-f5e9-42ac-9756-ebcd5be0ab03.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SUTRO BIOPHARMA, INC. (STRO)
CIK: 0001382101
Period of Report: 2021-01-14
Reporting Person: Hallam Trevor (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-14 | Common Stock | M | 19405 | $4.36 | Acquired | 56117 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-14 | Employee Stock Option (right to buy) | $4.36 | M | 19405 | Disposed | 2022-09-19 | Common Stock (19405) | Direct |
Footnotes
F1: The option is fully vested and exercisable.
More from SUTRO BIOPHARMA, INC.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 22
Capital/Financing Update
2026
Apr 1
Capital/Financing Update
2026
Mar 23
Annual Report
2026
Mar 23
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3